184020 Multi-country comparative assessment of avian influenza (H5N1) human cases surveillance in Asian countries

Monday, October 27, 2008: 10:30 AM

Hitoshi Murakami, MD, MPH, PhD , Bureau of International Cooperation, International Medical Center of Japan, Tokyo, Japan
Yutaka Ishida, MD, DTMH , Bureau of International Cooperation, International Medical Center of Japan, Tokyo, Japan
Masahiro Tanaka, MD, MSc , Department of Survey, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
Lynn Huynh, BA, MBA, MPH , Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Although different opinions exist if the H5N1 will be the next human pandemic strain, a future novel influenza pandemic is considered inevitable. Once the pandemic occurs, it will be a serious public health emergency without borders. Effective surveillance system, especially in countries with confirmed H5N1 human cases, is vital for early detection of the pandemic that may lead to either rapid containment or swifter mitigation measures of public health impacts such as preparation of pandemic vaccines. In purpose of aiding rational policy directions in strengthening the surveillance in Asian countries with necessary international assistances, a multi-country comparative assessment of the surveillance of H5N1 human cases was conducted. The study applied both reviews of published protocols, guidelines and policy documents, and key informant interviews on public health officials, both central and local, regarding surveillance implementations and responses to avian and human cases. Different aspects of the surveillance, namely definitions of reportable condition, reporting mechanisms, reporting sensitivities per population, specimens collection and shipment mechanisms, laboratory testing and responses to avian and human cases, were compared amongst Indonesia, Vietnam, Myanmar, Pakistan and Japan. Routine reporting of suspected cases from all health facilities was considered essential whereas community-based cluster reporting or active searches of human cases around poultry outbreaks alone did not ensure sufficient population-based reporting sensitivity and area coverage. Countries envisaged very diverse domestic laboratory network for sub-typing. One developing country even planned to install more than 30 laboratories nationwide that may potentially cause problems of quality control and biosafety. In response operations, major difference was observed whether to isolate close contacts in households or not. Above major findings indicate a large diversity in surveillance structures, implementations and performances across different countries. Knowledge sharing and mutual learning as well as multi-country stewardship are essential for optimizing the surveillance in each country.

Learning Objectives:
1. Acquire information regarding structure, operation and performance of avian influenza (H5N1) human cases surveillance in Asian countries (most of which have confirmed human H5N1 case incidence). 2. Recognize the diversity in operational prototypes of H5N1 human cases surveillance in Asia. 3. Analyze the H5N1 human cases surveillance of their own state/country and identify good practices in Asia that are applicable to it, and good practices in their own system that are applicable to Asia.

Keywords: Surveillance, Infectious Diseases

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a chief researcher of the entrusted research on international medical cooperation by the International Medical Center of Japan, Ministry of Health, Labour and Welfare, Japan (code 18-C-2) focusing on the international health collaboration for effective responses to international infectious diseases outbreaks. I have 12 years of working experiences in infectious diseases control (mainly vaccine preventable ones) and have been researching on the topics of the international collaboration for building preparedness against pandemic influenza in past two years. I have acquired my master of public health degree at Harvard School of Public Health and PhD degree at the University of Tokyo. I have three publications related to international infectious diseases control in international peer review journals (one undergoing revision).
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.